The interfering RNA (siRNA) sequences targeting Brachyury: (si-Brachyury#1)-5′-GCUGAACUCCUUGCAUAAG-3′; (si-Brachyury#2)-5′-GCUUAUCAGAACGAGGAGA-3′; the siRNA sequences targeting E2F3: (si-E2F3#1)-5′-GCGGUAUGAUACGUCUCUU-3′; (si-E2F3#2)-5′-GCAUCCACCUCAUUAAGAA-3′; the positive control siRNA: (si-GAPDH)-5′-UGACCUCAACUACAUGGUU-3′ and the negative control siRNA (si-NC)-5′-UUCUCCGAACGUGUCACGU-3′ were purchased from GenePharma (Shanghai, China). Brachyury, E2F3, and the negative control siRNAs were transfected into MCF-7 and MDA-MB-231 cells with Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. Sh-Brachyury and empty vector (GenePharma) were stably transfected into MDA-MB-231 cells. Cells were harvested for analysis at 48 h post-transfection.
Empty vector
Empty vector is a plasmid DNA construct without any genetic insert. It serves as a backbone for cloning and expression of recombinant proteins in various host cells. The empty vector provides the essential elements required for DNA replication, selection, and transcription regulation.
Lab products found in correlation
15 protocols using empty vector
Knockdown of Brachyury and E2F3 in Breast Cancer Cells
The interfering RNA (siRNA) sequences targeting Brachyury: (si-Brachyury#1)-5′-GCUGAACUCCUUGCAUAAG-3′; (si-Brachyury#2)-5′-GCUUAUCAGAACGAGGAGA-3′; the siRNA sequences targeting E2F3: (si-E2F3#1)-5′-GCGGUAUGAUACGUCUCUU-3′; (si-E2F3#2)-5′-GCAUCCACCUCAUUAAGAA-3′; the positive control siRNA: (si-GAPDH)-5′-UGACCUCAACUACAUGGUU-3′ and the negative control siRNA (si-NC)-5′-UUCUCCGAACGUGUCACGU-3′ were purchased from GenePharma (Shanghai, China). Brachyury, E2F3, and the negative control siRNAs were transfected into MCF-7 and MDA-MB-231 cells with Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. Sh-Brachyury and empty vector (GenePharma) were stably transfected into MDA-MB-231 cells. Cells were harvested for analysis at 48 h post-transfection.
Transfection of shRNA, miRNAs, and Plasmids
Lentiviral Transduction and Plasmid Transfection
LRP6 vectors, including LRP6 expression vector, empty vector, LRP6 siRNA and control, were acquired from Genepharm Co. Ltd (Shanghai, China). The LRP6 plasmid, LRP6 siRNA and a scramble siRNA were gained from Sangon Biotech Co., Ltd. (Shanghai, China). Using six-well plate seeded cells with a concentration of 2×106 per well. Employing Lipofectamine 2000 Reagent (Invitrogen Life Technologies) transfected the treated cells with 100 nm above vectors.
Modulating KISS-1 Expression in Osteosarcoma
Lentiviral Transduction of DDR1 and COL4A1 Silencing in RT4 Cells
Overexpression and Knockdown of E2F1
LUNAR1 Silencing and IGF-1R Overexpression in Colorectal Cancer
Optimizing BMSC Transfection for Wnt3a Silencing
Stable BMP2 Overexpression in S18 and 6-10B Cells
Functional Validation of m6A Regulators in BMSCs
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!